Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss

Abstract Background The glucocorticoid receptor gene (NR3C1) encodes the receptor to which cortisol and other glucocorticoids bind. Steroids in either oral, intratympanic, or intravascular forms are the treatment of choice for sudden sensorineural hearing loss (SSNHL), but the outcome varies. The ou...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen-Yu Chien, Shu-Yu Tai, Kuan-Hui Li, Hua-Ling Yang, Ling-Feng Wang, Kuen-Yao Ho, Ning-Chia Chang
Format: Article
Language:English
Published: SAGE Publishing 2023-02-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Online Access:https://doi.org/10.1186/s40463-022-00601-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565302189096960
author Chen-Yu Chien
Shu-Yu Tai
Kuan-Hui Li
Hua-Ling Yang
Ling-Feng Wang
Kuen-Yao Ho
Ning-Chia Chang
author_facet Chen-Yu Chien
Shu-Yu Tai
Kuan-Hui Li
Hua-Ling Yang
Ling-Feng Wang
Kuen-Yao Ho
Ning-Chia Chang
author_sort Chen-Yu Chien
collection DOAJ
description Abstract Background The glucocorticoid receptor gene (NR3C1) encodes the receptor to which cortisol and other glucocorticoids bind. Steroids in either oral, intratympanic, or intravascular forms are the treatment of choice for sudden sensorineural hearing loss (SSNHL), but the outcome varies. The outcomes of SSNHL have been investigated for related factors, including age, initial hearing loss severity and pattern, vertigo, genetic variations, and the time between onset and treatment. The objective of the present study was to analyze the association of genetic polymorphisms of NR3C1 with the outcomes of SSNHL. Materials and methods We conducted a comparison study of 93 cases with a poor outcome (control) and 100 cases with a good outcome (case) in SSNHL patients. Six single nucleotide polymorphisms (SNPs) were selected. The genotypes were determined using TaqMan technology. Results The heterozygous AT genotype of rs17100289 was associated with a poor outcome in comparison with the major homozygous AA genotype after adjustments for age and sex (OR = 0.50; 95% CI 0.26–0.95; P = 0.035) in SSNHL patients. The CT genotype of rs4912912 was also associated with a poor outcome compared with the major homozygous TT genotype after the adjustments (OR = 0.47; 95% CI 0.24–0.92; P = 0.026). Conclusion These results suggest that NR3C1 genetic polymorphisms may influence the outcomes of SSNHL. Graphical Abstract
format Article
id doaj-art-567c701726c4414987362e6deaeb70ce
institution Kabale University
issn 1916-0216
language English
publishDate 2023-02-01
publisher SAGE Publishing
record_format Article
series Journal of Otolaryngology - Head and Neck Surgery
spelling doaj-art-567c701726c4414987362e6deaeb70ce2025-02-03T01:08:31ZengSAGE PublishingJournal of Otolaryngology - Head and Neck Surgery1916-02162023-02-015211710.1186/s40463-022-00601-wGlucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing lossChen-Yu Chien0Shu-Yu Tai1Kuan-Hui Li2Hua-Ling Yang3Ling-Feng Wang4Kuen-Yao Ho5Ning-Chia Chang6Department of Otorhinolaryngology, Kaohsiung Medical University Hospital, Kaohsiung Medical UniversityDepartment of Family Medicine, School of Medicine, College of Medicine, Kaohsiung Medical UniversityDepartment of Otorhinolaryngology, Kaohsiung Medical University Hospital, Kaohsiung Medical UniversityDivision of Hepatobiliary and Pancreatic Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical UniversityDepartment of Otorhinolaryngology, Kaohsiung Medical University Hospital, Kaohsiung Medical UniversityDepartment of Otorhinolaryngology, Kaohsiung Medical University Hospital, Kaohsiung Medical UniversityDepartment of Otorhinolaryngology, Kaohsiung Medical University Hospital, Kaohsiung Medical UniversityAbstract Background The glucocorticoid receptor gene (NR3C1) encodes the receptor to which cortisol and other glucocorticoids bind. Steroids in either oral, intratympanic, or intravascular forms are the treatment of choice for sudden sensorineural hearing loss (SSNHL), but the outcome varies. The outcomes of SSNHL have been investigated for related factors, including age, initial hearing loss severity and pattern, vertigo, genetic variations, and the time between onset and treatment. The objective of the present study was to analyze the association of genetic polymorphisms of NR3C1 with the outcomes of SSNHL. Materials and methods We conducted a comparison study of 93 cases with a poor outcome (control) and 100 cases with a good outcome (case) in SSNHL patients. Six single nucleotide polymorphisms (SNPs) were selected. The genotypes were determined using TaqMan technology. Results The heterozygous AT genotype of rs17100289 was associated with a poor outcome in comparison with the major homozygous AA genotype after adjustments for age and sex (OR = 0.50; 95% CI 0.26–0.95; P = 0.035) in SSNHL patients. The CT genotype of rs4912912 was also associated with a poor outcome compared with the major homozygous TT genotype after the adjustments (OR = 0.47; 95% CI 0.24–0.92; P = 0.026). Conclusion These results suggest that NR3C1 genetic polymorphisms may influence the outcomes of SSNHL. Graphical Abstracthttps://doi.org/10.1186/s40463-022-00601-wNuclear receptor subfamily 3 Group C member 1 (NR3C1)Genetic polymorphismOutcomesSteroid receptor genesudden sensorineural hearing loss
spellingShingle Chen-Yu Chien
Shu-Yu Tai
Kuan-Hui Li
Hua-Ling Yang
Ling-Feng Wang
Kuen-Yao Ho
Ning-Chia Chang
Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
Journal of Otolaryngology - Head and Neck Surgery
Nuclear receptor subfamily 3 Group C member 1 (NR3C1)
Genetic polymorphism
Outcomes
Steroid receptor gene
sudden sensorineural hearing loss
title Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
title_full Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
title_fullStr Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
title_full_unstemmed Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
title_short Glucocorticoid receptor (NR3C1) genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
title_sort glucocorticoid receptor nr3c1 genetic polymorphisms and the outcomes of sudden sensorineural hearing loss
topic Nuclear receptor subfamily 3 Group C member 1 (NR3C1)
Genetic polymorphism
Outcomes
Steroid receptor gene
sudden sensorineural hearing loss
url https://doi.org/10.1186/s40463-022-00601-w
work_keys_str_mv AT chenyuchien glucocorticoidreceptornr3c1geneticpolymorphismsandtheoutcomesofsuddensensorineuralhearingloss
AT shuyutai glucocorticoidreceptornr3c1geneticpolymorphismsandtheoutcomesofsuddensensorineuralhearingloss
AT kuanhuili glucocorticoidreceptornr3c1geneticpolymorphismsandtheoutcomesofsuddensensorineuralhearingloss
AT hualingyang glucocorticoidreceptornr3c1geneticpolymorphismsandtheoutcomesofsuddensensorineuralhearingloss
AT lingfengwang glucocorticoidreceptornr3c1geneticpolymorphismsandtheoutcomesofsuddensensorineuralhearingloss
AT kuenyaoho glucocorticoidreceptornr3c1geneticpolymorphismsandtheoutcomesofsuddensensorineuralhearingloss
AT ningchiachang glucocorticoidreceptornr3c1geneticpolymorphismsandtheoutcomesofsuddensensorineuralhearingloss